Furthermore, DMC alone has been shown to induce tumor-associated brain endothelial cell death through GRP78 and CHOP induction (82), suggesting that DMC is better drug of choice than celecoxib to be used in conjunction with bortezomib. The gene discussed is HSPA5; the disease is neoplasm.